week 1 tirzepatide What to Know Before Starting for Medical Weight Loss GLP1 week 3 update |

*Correspondence: Alessio Mazzieri, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Testing b12 levels during treatment provides the best way to identify any individual decline rather than assuming everyone needs supplementation

In the ELIXA and the EXSCEL trials, GLP-1RAs (once daily lixisenatide and once weekly exenatide, respectively) didnt provide benefit in MACE reduction compared to placebo, but were non-inferior to placebo for the primary composite outcome of MACE

Watching insulin levels decline during Retatrutide treatment confirms improving metabolic function even when glucose changes seem modest